Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04312269 · ClinicalTrials.gov registry record · NA

Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke

A NA study of Stroke, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT04312269 is a NA study of Stroke that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 70 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04312269, a NA study of Stroke, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors.

Conditions Studied

Interventions

  • OTHER Targeted Memory Reactivation (TMR)

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2020-02-25
Est. Completion 2026-01-30
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04312269

The ClinicalTrials.gov registry entry for NCT04312269 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Targeted Memory Reactivation (TMR) is the first listed.

NCT04312269 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04312269 about?

NCT04312269 is a clinical study titled "Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke". This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended trai...

What is the current status of trial NCT04312269?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2020-02-25. Estimated completion is 2026-01-30.

What conditions does trial NCT04312269 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04312269?

The interventions under investigation include: Targeted Memory Reactivation (TMR) (OTHER).

Who is sponsoring clinical trial NCT04312269?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04312269 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.